BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹140 Cr | ₹131 Cr | ₹104 Cr | ₹110 Cr | ₹118 Cr |
What is the latest Total Debt ratio of BAL PHARMA ?
Year | Total Debt |
---|---|
Mar2024 | ₹140 Cr |
Mar2023 | ₹131 Cr |
Mar2022 | ₹104 Cr |
Mar2021 | ₹110 Cr |
Mar2020 | ₹118 Cr |
How is Total Debt of BAL PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹140 Cr | 6.56 | |
Mar2023 | ₹131 Cr | 26.40 | |
Mar2022 | ₹104 Cr | -5.80 | |
Mar2021 | ₹110 Cr | -7.12 | |
Mar2020 | ₹118 Cr | - |
Compare Total Debt of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹166.9 Cr | -5.3% | -10.1% | -10.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -5.3% |
-10.1% |
-10.5% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses